These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2439826)

  • 41. A comparison between metoprolol and pindolol in the treatment of essential hypertension.
    Tuomilehto J; Pohjola M
    Ann Clin Res; 1978 Feb; 10(1):24-9. PubMed ID: 28070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MIS (Multicentric Isradipine Study of antihypertensive therapy).
    Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
    Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
    Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
    Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Beta-blockers in the treatment of hypertension in elderly patients].
    Lefflerová K; Widimský J; Lupínek Z
    Vnitr Lek; 1991 Feb; 37(2):128-34. PubMed ID: 1673577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
    Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bopindolol: a new long acting beta-receptor antagonist; its effects on haemodynamics, and on the renin response to tilting.
    Turner DR; Goodwin FJ; Knight AR; Littlejohns DW; Sharman VL; Vere DW
    Br J Clin Pharmacol; 1984 Mar; 17(3):295-9. PubMed ID: 6143566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
    Rapola JM; Pellinen TJ; Toivonen L; Nieminen MS
    Ann Med; 1990; 22(4):221-4. PubMed ID: 2248757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Dorow P; Schiess W
    Klin Wochenschr; 1986 Apr; 64(8):366-9. PubMed ID: 2871220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics after a single oral dose of bopindolol in patients with cirrhosis.
    Wensing G; Branch RA; Humbert H; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1990; 39(6):569-72. PubMed ID: 1982762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
    Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
    Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
    Hosie J; Dahlöf B; Klein G
    Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure.
    Gould BA; Hornung RS; Kieso H; Mann S; Raftery EB
    Br J Clin Pharmacol; 1982 Dec; 14(6):827-31. PubMed ID: 6129883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH
    Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
    Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem.
    Meyer EC; Makov UE; Palant A
    Cardiology; 1991; 78(3):179-84. PubMed ID: 1678316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of bopindolol on renal function.
    Fabre J; Wintsch J; Peter-Contesse R; Bouchardy C; Liniger C; Favre L; Donath A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S45-50. PubMed ID: 2439819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and pharmacodynamics of a new transdermal delivery system for bopindolol.
    Drewe J; Meier R; Timonen U; Thumshirn M; Munzer J; Kissel T; Gyr K
    Br J Clin Pharmacol; 1991 Jun; 31(6):671-6. PubMed ID: 1678271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.